Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKVLBFXELLBBB
Date   Source Headline
9th May 201212:32 pmRNSInterim Management Statement
3rd May 201212:21 pmRNSAnnual Information Update
2nd May 201210:48 amRNSDividend
30th Apr 20121:06 pmRNSTotal Voting Rights
27th Apr 201211:00 amRNSDirector Declaration
11th Apr 201210:10 amRNSAnnual Financial Report
3rd Apr 201212:00 pmRNSDirector/PDMR Shareholding
2nd Apr 201212:13 pmRNSDirector Declaration
30th Mar 201210:50 amRNSTotal Voting Rights
26th Mar 201212:15 pmRNSBlocklisting Interim Review
20th Mar 201211:37 amRNSDirector/PDMR Shareholding
20th Mar 20128:51 amRNSAdditional Listing
19th Mar 201210:28 amRNSDirector/PDMR Shareholding
16th Mar 201210:43 amRNSDirector/PDMR Shareholding
15th Mar 201210:50 amRNSDirector/PDMR Shareholding
14th Mar 201210:31 amRNSDirector/PDMR Shareholding
1st Mar 20129:06 amRNSDirectorate Change and Declaration
1st Mar 20129:06 amRNSFinal Results
6th Feb 201211:20 amRNSNotice of 2011 Final Results
30th Dec 20119:14 amRNSDirectorate Change
9th Nov 20119:10 amRNSInterim Management Statement
31st Oct 201111:13 amRNSTotal Voting Rights
6th Oct 201111:57 amRNSDirector/PDMR Shareholding
3rd Oct 201110:22 amRNSDirector Declaration
29th Sep 201111:15 amRNSDirectorate Change
28th Sep 201110:24 amRNSDividend
26th Sep 201110:21 amRNSBlocklisting Interim Review
28th Jul 201110:05 amRNSHalf Yearly Report
30th Jun 201110:27 amRNSNotice of 2011 Half-Yearly Results
31st May 201110:42 amRNSTotal Voting Rights
12th May 20111:14 pmRNSDirectorate Change
11th May 20112:18 pmRNSAGM Statement
11th May 20112:11 pmRNSResult of AGM
11th May 201112:31 pmRNSInterim Management Statement
5th May 201111:28 amRNSDirector/PDMR Shareholding
4th May 201110:16 amRNSDividend
3rd May 201111:37 amRNSAnnual Information Update
7th Apr 201110:37 amRNSAnnual Financial Report
31st Mar 201110:46 amRNSDirector/PDMR Shareholding
31st Mar 201110:40 amRNSTotal Voting Rights
25th Mar 20119:22 amRNSBlocklisting Interim Review
22nd Mar 20118:54 amRNSAdditional Listing
16th Mar 20119:24 amRNSDirector/PDMR Shareholding
3rd Mar 20119:05 amRNSFinal Results
7th Feb 20119:14 amRNSNotice of 2010 Final Results
31st Dec 20107:12 amRNSTotal Voting Rights
15th Dec 201010:11 amRNSDirector/PDMR Shareholding
14th Dec 20109:37 amRNSDirector/PDMR Shareholding
13th Dec 201010:01 amRNSDirector/PDMR Shareholding
10th Dec 20109:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.